Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole Compared With Rabeprazole in Patients With Duodenal Ulcers.

NCT04215653 is registered in ClinicalTrials.gov with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor.

NCT NCT04215653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04215653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole Compared With Rabeprazole in Patients With Duodenal Ulcers.
Lead sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
January 20, 2020
Completion date
February 28, 2021
Enrollment
448 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

duodenal ulcer，du